Citation tools

Natwa, Mona et al "Survival Outcomes and Dosimetric Analysis of Iomab-B (131I-apamistamab) Followed by Allogeneic Hematopoietic Cell Transplant for Patients with TP53 Mutated Relapsed/Refractory AML." Journal of Nuclear Medicine 65.supplement 2 (2024): 241491. Web. 27 May. 2025.

Citation Manager Formats